Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Aug 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5090377016 | Prolonged-release intrauterine delivery system (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5090378014 | Prolonged-release intrauterine delivery system | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Prolonged-release intrauterine delivery system (dose form) | Is a | Intrauterine dose form | true | Inferred relationship | Some | ||
Prolonged-release intrauterine delivery system (dose form) | Has basic dose form (attribute) | System | true | Inferred relationship | Some | ||
Prolonged-release intrauterine delivery system (dose form) | Has dose form intended site (attribute) | Intrauterine (intended site) | true | Inferred relationship | Some | ||
Prolonged-release intrauterine delivery system (dose form) | Has dose form release characteristic (attribute) | Prolonged-release (release characteristic) | true | Inferred relationship | Some | ||
Prolonged-release intrauterine delivery system (dose form) | Has dose form transformation (attribute) | No transformation | true | Inferred relationship | Some | ||
Prolonged-release intrauterine delivery system (dose form) | Has dose form administration method (attribute) | Insert (administration method) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has manufactured dose form | True | Prolonged-release intrauterine delivery system (dose form) | Inferred relationship | Some | |
Levonorgestrel 19.5 mg prolonged-release intrauterine drug delivery system | Has manufactured dose form | True | Prolonged-release intrauterine delivery system (dose form) | Inferred relationship | Some | |
Product containing precisely levonorgestrel 13.5 milligram/1 each prolonged-release intrauterine drug delivery system (clinical drug) | Has manufactured dose form | True | Prolonged-release intrauterine delivery system (dose form) | Inferred relationship | Some |
This concept is not in any reference sets